Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Nov;42(11):5199-204.
doi: 10.1128/JCM.42.11.5199-5204.2004.

Assessment of the target-capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays

Affiliations
Comparative Study

Assessment of the target-capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays

Venkatakrishna Shyamala et al. J Clin Microbiol. 2004 Nov.

Abstract

Recent clinical studies suggest that hepatitis B virus (HBV) load and genotype may be independent predictors of responses to antiviral therapies. However, it is difficult for clinicians to accurately determine viral loads in patient samples because results--both the values and the units of measure--can vary greatly among different tests. Accordingly, the World Health Organization (WHO) has produced the first international standard for HBV DNA for nucleic acid amplification technology (NAT) assays. In the present study, we describe the performance of the target-capture PCR HBV DNA quantitative assay for the quantitation of HBV DNA in clinical samples and reference panels. The range of quantitation was between 50 and 10(10) IU/ml. The sensitivity and accuracy of the target-capture PCR assay were demonstrated by using the HBV panel from Quality Control for Medical Diagnostics (QCMD) and the WHO HBV DNA standard. The target-capture PCR assay quantitated the six genotype A members of the QCMD panel and dilutions of the WHO HBV DNA standard within an accuracy of 74 to 142%. Compared to current serological methods, the assay offers window period reductions of 19 days prior to HBV surface antigen and 26 days prior to HBV e antigen detection. The target-capture PCR assay was also compared with four commercially available NAT assays, and the various units of measure were standardized with respect to the international units of the WHO HBV DNA standard. The target-capture PCR assay is a sensitive, accurate, high-throughput, rapid, and reproducible assay for the determination of HBV loads.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Benjamin, R. J. 2001. Nucleic acid testing: update and applications. Semin. Hematol. 38:11-16. - PubMed
    1. Berger, A., W. Preiser, and H. W. Doerr. 2001. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J. Clin. Virol. 20:23-30. - PubMed
    1. Biswas, R., E. Tabor, C. C. Hsia, D. J. Wright, M. E. Laycock, E. W. Fiebig, L. Peddada, R. Smith, G. B. Schreiber, J. S. Epstein, G. J. Nemo, and M. P. Busch. 2003. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43:788-798. - PubMed
    1. Busch, M. P., and S. H. Kleinman. 2000. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases. Transfusion 40:143-159. - PubMed
    1. Grant, P. R., and M. P. Busch. 2002. Nucleic acid amplification technology methods used in blood donor screening. Transfusion Med. 12:229-242. - PubMed